Skip to main content
. 2010 Apr 18;28(4):537–542. doi: 10.1007/s00345-010-0556-0

Fig. 2.

Fig. 2

Microcirculatory changes of vMIP-II treatment. vMIP-II treatment significantly improved functional capillary density (p < 0.05), while red blood cell velocity (RBCV) remained unchanged. Leukocyte–endothelial interaction was significantly reduced by vMIP-II showing fewer firm adherent leukocytes at the vessel wall in vivo (p < 0.05)